Fibrous papule of the face is a benign, clinically indistinct papule, also known as sporadic angiofibroma.
In the past, fibrous papule has been suggested to have been derived from preexisting or involuting melanocytic nevi; however, subsequent investigations appear to have refuted this and have confirmed a relationship to factor XIIIa – positive dermal dendrocytes. Fibrous papule is best considered a variant of angiofibroma. 
A study from 2014 showed expression of antibodies against p-mTOR in dermal stromal cells and epidermal keratinocytes in fibrous papules, similar to tuberous-sclerosis complex–associated facial angiofibromas, suggesting topical rapamycin may be a treatment option. 
The condition is relatively common.
No racial predilection is known.
Both sexes are equally affected.
Most of the patients are in their third to fifth decade of life.
Fibrous papule of the face is a benign lesion. Most of the lesions are asymptomatic, although one third of patients have reported bleeding following minor trauma.
The patient should be reassured that the lesion is harmless. Patients should also be made aware that a surgical procedure results in a scar.